Warrant Premium definition

Warrant Premium means an amount equal to the Gross Warrant Proceeds reduced by the Net Warrant Proceeds.
Warrant Premium means the price of each warrant at 25% premium to the listing price at the time of the Listing Event or acquisition price at the time of the Acquisition Event (as applicable).
Warrant Premium means an amount equal to $0.125 multiplied by the number of shares of Common Stock for which the Warrant is initially exercisable.

Examples of Warrant Premium in a sentence

  • The Company further covenants and agrees that neither it nor any of its affiliates will purchase any Shares prior to earlier of the Additional Warrant Premium Payment Date and the Early Unwind Date (as defined below).

  • In addition, Borrower hereby acknowledges that if the Anschutz Option is exercised, Lender will be entitled to receive the Warrant Premium, which Warrant Premium shall be retained by Lender and will not be applied to the Indebtedness.

  • In the event that the Purchase Agreement is terminated pursuant to Article 3 thereof prior to the issuance of any Preferred Shares pursuant thereto, then this Note (to the extent, and only to the extent, that this Note is issued as payment of the Warrant Premium) shall automatically be cancelled upon such termination and shall be of no further force or effect.

  • The Company hereby repeats the representations and warranties set forth in Section 8 and Sections 9(f), (g) and (h) of the Confirmation; provided that the Company shall be deemed to repeat the representation contained in Section 8(e) of the Confirmation on each day during the period beginning on the date hereof and ending on the Additional Warrant Premium Payment Date.

  • On the Closing Date: (i) the Company shall deliver the Warrant duly executed on behalf of the Company and registered in the name of Investor or its designee and (ii) Investor shall pay the Warrant Premium to the Company.

  • Investor shall pay the Warrant Premium, at its option, either in cash or through the issuance of a recourse note to the Company in the form attached as Exhibit G to this Agreement.

Related to Warrant Premium

  • Warrant Price as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants.

  • Current Warrant Price means, in respect of a share of Common Stock at any date herein specified, the price at which a share of Common Stock may be purchased pursuant to this Warrant on such date.

  • Net Premium means the premium, net of reinsurance premiums paid, HRA and GME payments, and MCO tax expenses.

  • Prepayment Premium means, with respect to the Mortgage Loan, any prepayment premium, spread maintenance premium, yield maintenance premium or similar fee required to be paid in connection with a prepayment of the Mortgage Loan pursuant to the Mortgage Loan Documents, including any exit fee.

  • Warrant Value means the fair value of all warrants, options and other similar rights issued to a third party in connection with an Other Financing, determined by using a standard Black-Scholes option-pricing model using an expected volatility percentage as shall be mutually agreed by the Investor and the Company. In the case of a dispute relating to such expected volatility assumption, the Investor shall obtain applicable volatility data from three investment banking firms of nationally recognized reputation, and the parties hereto shall use the average thereof for purposes of determining the expected volatility percentage in connection with the Black-Scholes calculation referred to in the immediately preceding sentence. Reference is made to the Common Stock Purchase Agreement dated as of December 20, 2010, (the “Purchase Agreement”) between Poniard Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Washington (the “Company”), and Small Cap Biotech Value, Ltd., a business company incorporated under the laws of the British Virgin Islands. Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.1 of the Purchase Agreement, the Company hereby issues this Fixed Request Notice to exercise a Fixed Request for the Fixed Amount Requested indicated below. Optional Amount Dollar Amount: Pricing Period start date: Pricing Period end date: Settlement Date: Fixed Request Threshold Price: Optional Amount Threshold Price: Dollar Amount of Common Stock Currently Unissued under the Registration Statement Dollar Amount of Common Stock Currently Available under the Aggregate Limit: Dated: By: Name: Title: Address: Facsimile No.: AGREED AND ACCEPTED Name: Title: Fax#: Reference is made to the Common Stock Purchase Agreement dated as of December 20, 2010 (the “Purchase Agreement”) between Poniard Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Washington (the “Company”), and Small Cap Biotech Value, Ltd., a business company incorporated under the laws of the British Virgin Islands (the “Investor”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.11 of the Purchase Agreement, the Investor hereby issues this Optional Amount Notice to exercise an Optional Amount for the Optional Amount Dollar Amount indicated below. Number of Shares to be purchased VWAP on the date hereof: Discount Price: Settlement Date: Threshold Price: Dated: By: Name: Title: Address: Facsimile No.: The undersigned, the [ ] of Poniard Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Washington (the “Company”), delivers this certificate in connection with the Common Stock Purchase Agreement, dated as of December 20, 2010 (the “Agreement”), by and between the Company and Small Cap Biotech Value, Ltd., a business company incorporated under the laws of the British Virgin Islands (the “Investor”), and hereby certifies on the date hereof that (capitalized terms used herein without definition have the meanings assigned to them in the Agreement):